Boric acid ovicidal trap for the management of Aedes species.

Journal of vector borne diseases (2015-06-30)
L Charlet Bhami, S Sam Manohar Das
ABSTRACT

The use of low concentrations of boric acid as a potential and effective control agent for the eggs and immature stages of Aedes aegypti L. and Aedes albopictus Skuse (Diptera: Culicidae) is found to be safe and effective as compared to synthetic chemical insecticides. The study aims to determine the ovicidal concentration of boric acid, its effective concentration for oviposition attraction and the larval mortality concentration for Ae. aegypti and Ae. albopictus. The ovicidal concentration of boric acid was determined by incubating the eggs in different concentrations of boric acid (0.1, 0.25, 0.5, 0.75 and 1%). Different dilutions of boric acid were taken in the oviposition cup and the ovicidal concentration, effective concentration for oviposition attraction and the mean survival/mortality rate of III and IV instar Ae. aegypti and Ae. albopictus larvae were determined. The ovicidal concentration of boric acid for 100% mortality in Aedes sp eggs is 1%. Effective concentration for the oviposition attraction is 0.5%. At 1% concentration, larvae of both the species died within 24 h. Boric acid is less toxic compared to different pesticides, and in low concentrations, it attracts the ovipositing female Aedes sp as well as fertile males. Dilute boric acid solution is an effective ovitrap since the eggs laid by mosquitoes either die or the larvae that hatch out from them do not survive in boric acid. Boric acid kills the males that come in contact with the solution, which are attracted to the trap by the females hovering around.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Boric acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., buffer substance, ≥99.8%
Sigma-Aldrich
Boric acid, puriss., meets analytical specification of Ph. Eur., BP, NF, 99.5-100.5%, powder

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.